A Comprehensive Review on Chemical Structures and Bioactivities of <i>Ostropomycetidae</i> Lichens

Lichenized fungi, recognized as an ecologically vital and pharmaceutically promising resource, hold substantial value in both environmental conservation and medicinal applications. As the second largest subclass within the lichen-forming fungi of Lecanoromycetes, <i>Ostropomycetidae</i>...

Full description

Saved in:
Bibliographic Details
Main Authors: Yunhui Wang, Chengyue Hao, Shuhao Jiang, Yanhu Ju, Wei Li, Zefeng Jia
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Journal of Fungi
Subjects:
Online Access:https://www.mdpi.com/2309-608X/11/5/369
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Lichenized fungi, recognized as an ecologically vital and pharmaceutically promising resource, hold substantial value in both environmental conservation and medicinal applications. As the second largest subclass within the lichen-forming fungi of Lecanoromycetes, <i>Ostropomycetidae</i> emerged as a critical reservoir of bioactive secondary metabolites. Current research has revealed that these secondary metabolites demonstrate remarkable bioactivities, positioning them as potential sources for novel pharmaceutical compounds. Despite considerable progress in characterizing chemical constituents and evaluating bioactivities within this subclass, a systematic summary of these discoveries remains absent. This review synthesizes the lichenochemical research progress, providing critical evaluations of 202 structurally characterized compounds from <i>Ostropomycetidae</i> lichen species over recent decades. These <i>Ostropomycetidae</i>-derived compounds cover the phenols, polyketides, fatty acids, terpenoids, steroids, and non-ribosomal peptides, and exhibit diverse bioactivities including antitumor, anti-inflammatory, antibacterial, antifungal, antiviral, antioxidant, anti-angiogenic, anti-neurodegenerative diseases, antitubercular, anti-herbivore, and antitrypanosomal, and so on. The aim of this review is to establish a robust chemodiversity framework and to offer strategic guidance for targeted exploration of lichen-derived drug candidates in the biological resources of <i>Ostropomycetidae</i> lichens.
ISSN:2309-608X